İçeriğe geç

Jia Luo, MD

@jia-luo.bsky.social did:plc:55ap2eggmhhlp5sr4n27nu5u

Thoracic medical oncologist and cancer researcher at Dana-Farber/ Harvard Cancer Center // Prev MSKCC Fellow, OHSU IM & Chief Res, Stanford Med, and UW-Madison https://t.co/Y9HwVQ1jyq

Bluesky’a katılma tarihi:

Takipçi
1.219
Takip edilen
149
Post
114
Sıralamaya girdiği gün
0

Özet

Jia Luo, MD (@jia-luo.bsky.social), 8 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 1.219 takipçisi var, 149 hesabı takip ediyor ve 114 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • Nandita Garud@nanditagarud.bsky.social

    Grateful to share our paper on gene-specific selective sweeps in human gut microbiomes, now out in Nature! It has been a joy to work with @rwolff.bsky.social, whose insights and hard work made this possible. www.nature.com/articles/s41...

    Postu göster
  • Dana-Farber Cancer Institute@danafarber.bsky.social

    Please join us for a webinar on What to Know About Lung Cancer. Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology will share insights on prevention, early detection, and the latest treatment advancements, followed by a Q&A. Register here: bit.ly/3L9ZmjA

    Postu göster
  • Dana-Farber News@danafarbernews.bsky.social

    Congratulations to Dr. Chris Lathan of @danafarber.bsky.social, recipient of the Randolph W. “Bill” Bromery Legacy Award from @umassamherst.bsky.social for his deep commitment to social justice, diversity, equity, and inclusion. ➡️ bit.ly/4qvbFao 📷 Stephanie Berenson Photography

    Postu göster
  • Stacie Dusetzina@dusetzinas.bsky.social

    Absolutely thrilled to be a member of the National Academy of Medicine! Lifetime career achievement unlocked! Cannot thank my persistent nominators enough for this honor. Congratulations to the new cohort - it is so fun to see so many deserving people be recognized! nam.edu/news-and-ins...

    Postu göster
  • Dana-Farber Cancer Institute@danafarber.bsky.social

    Pasi A. Jänne, MD, MPH, is back on stage sharing advancing targeted therapy research for patients with KRAS G12C-mutated NSCLC, highlighting emerging strategies and growing momentum in lung cancer treatment. #ESMO25

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.